Hong Kong Food Stock News

SEHK:1221
SEHK:1221Hospitality

Sino Hotels (Holdings) And 2 Other Promising Global Penny Stocks

Global markets have recently experienced volatility, with U.S. stocks declining amid concerns over the disruptive potential of artificial intelligence, while European and Asian markets showed mixed performances. For investors interested in smaller or newer companies, penny stocks—despite their somewhat outdated name—remain a relevant investment area offering potential value. These stocks can provide a mix of affordability and growth potential when supported by strong financial health, making...
SEHK:2038
SEHK:2038Electronic

FIH Mobile (SEHK:2038) Valuation Check As Board Weighs Final Results And Dividend In March

FIH Mobile (SEHK:2038) has scheduled a March board meeting to review its audited final results for the year ended 31 December 2025 and to consider a potential final dividend, drawing fresh attention from income focused investors. See our latest analysis for FIH Mobile. At a latest share price of HK$21.0, FIH Mobile has seen momentum build in recent months, with a 30 day share price return of 7.58%, a 90 day share price return of 16.34%, and a 1 year total shareholder return of 128.26% that...
SEHK:173
SEHK:173Real Estate

Asian Penny Stocks With Market Caps Up To US$3B

As global markets grapple with AI disruption concerns and fluctuating economic indicators, Asian stocks continue to present a diverse landscape for investors. Penny stocks, while often seen as relics of past trading days, remain an intriguing area for those looking to uncover hidden value in smaller or newer companies. By focusing on firms with robust financials and potential growth trajectories, investors can find compelling opportunities that balance risk with the promise of significant...
SEHK:2171
SEHK:2171Biotechs

Assessing CARsgen Therapeutics Holdings’ Valuation After New CAR T-Cell Manufacturing Cooperation News

CARsgen Therapeutics Holdings (SEHK:2171) has signed cooperation agreements via its subsidiary CARsgen Diagnostics with Shanghai Jingong Enterprise to build a commercial CAR T-cell manufacturing base in Shanghai, a move closely linked to its commercialization plans. See our latest analysis for CARsgen Therapeutics Holdings. The cooperation news comes as momentum in CARsgen Therapeutics Holdings' share price has recently picked up, with a 1-day share price return of 4.65% and a 7-day share...
SEHK:2460
SEHK:2460Beverage

Assessing China Resources Beverage (Holdings) (SEHK:2460) Valuation After CFO Transition To Huang Hu

CFO transition puts leadership and financial oversight in focus China Resources Beverage (Holdings) (SEHK:2460) has announced a CFO transition, with Ms. Wu Xia resigning and long-time group executive Ms. Huang Hu stepping into the role, drawing attention to the company’s financial leadership. See our latest analysis for China Resources Beverage (Holdings). At a latest share price of HK$10.68, China Resources Beverage (Holdings) has recorded a 1-month share price return of 4.30% and a year to...
SEHK:6823
SEHK:6823Telecom

A Look At HKT Trust And HKT (SEHK:6823) Valuation After Earnings Growth And Higher Final Dividend

Earnings and dividend move into focus for HKT Trust and HKT (SEHK:6823) HKT Trust and HKT (SEHK:6823) is back on investors’ radar after reporting full year 2025 earnings and proposing a higher final dividend. This has drawn attention to both its cash generation and income profile. See our latest analysis for HKT Trust and HKT. Alongside the earnings and higher final dividend proposal, the share price has been firming, with a 30 day share price return of 4.83% and a 1 year total shareholder...
SEHK:268
SEHK:268Software

A Look At Kingdee International Software Group’s Valuation As Share Buybacks Begin Following Shareholder Approval

Buyback launch puts fresh focus on Kingdee’s capital allocation Kingdee International Software Group (SEHK:268) has started repurchasing its own shares after shareholder approval for a program that allows buybacks of up to 10% of the company’s issued share capital. The board expects these repurchases to support net asset value and earnings per share, funded from resources that comply with the company’s governing documents, Hong Kong listing rules and Cayman Islands law. See our latest...
SEHK:388
SEHK:388Capital Markets

Assessing Hong Kong Exchanges and Clearing (SEHK:388) Valuation After New Middle East Leadership Appointment

Why this new Middle East appointment matters for HKEX Hong Kong Exchanges and Clearing (SEHK:388) has appointed Jalal Almarhoon as Managing Director and Chief Regional Representative for the Middle East, putting him in charge of its newly opened Riyadh office. His remit covers issuer outreach, investor engagement and capital market connectivity across Saudi Arabia and the wider region. This puts fresh attention on how HKEX may build relationships that support future listing and trading...